Leading healthcare agency notches double-digit growth for first half, driven by digital shifts and full pipelines
While the ad industry is navigating a jittery economy — and the looming threat of marketing budget cuts — the pharma sector seems to be humming along. One proof point this week is Real Chemistry, the second-largest healthcare agency in North America, with a healthy first-half report and double-digit growth.
The digital communications and marketing company reported on Wednesday’s first half revenues of more than $270 million, a 21% increase compared to the first half of 2021. While the 2022 jump won’t surpass the pandemic affected 2020 to 2021 increase of 35%, Real Chemistry CEO Shankar Narayanan said it’s projecting full-year growth of 20%. Real Chemistry notched $439 million in 2021 sales, putting the projected 2022 full year at more than $525 million.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 153,800+ biopharma pros reading Endpoints daily — and it's free.